Skip to main content
Caplight Logo









Akeso Biomedical, Inc.

Akeso Biomedical, Inc.

Private
Burlington, MassachusettsHealthcare & Life Scienceshttps://akesobiomedical.com/

Last Round

Pre Seed

Feb 9, 2021

Total Funding Raised

$6.33M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Akeso Biomedical, Inc. is a food safety company that develops antibiotic-free feed additives to improve the gut health of farm animals and reduce bacterial infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

animal feed additivesantibiotic alternativesfood safetyanimal healthpathogen reductionFe3C technologyanimal gut healthagtechiron chelatefoodborne illness preventionzootechnical feed additivepoultry healthswine healthTYPLEX Chelateregulatory dossier services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Akeso Biomedical, Inc. Comparables

Compare Akeso Biomedical, Inc. with similar companies based on industry and business-model similarity.

Akeso Biomedical, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
General Probiotics
79%
Elogium Probiotics
79%
Cytophage Technologies
78%

Akeso Biomedical, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedFeb 9, 2021
Pre SeedNov 8, 2019
Series AMay 31, 2017
SeedJul 15, 2015
SeedDec 4, 2014

Key People

Founding team and executive leadership

Simon Williams

Chief Executive Officer

Executive Team

Akeso Biomedical, Inc. Investors

Notable investors and investment history

Akeso Biomedical, Inc. investors
InvestorRounds
VIC Technology Venture DevelopmentSeries A, Pre Seed, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 30% MoM.

  • Jul 26, 2026

    Monthly visitors grew 145% MoM, reaching 1.5K.

Akeso Biomedical, Inc. Filings

Explore SEC and related filing metadata, where available.

Akeso Biomedical, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Akeso Biomedical, Inc.'s valuation, stock price, and market status.

Is Akeso Biomedical, Inc. a public or private company?

Akeso Biomedical, Inc. is a private company.

What is the current stock price of Akeso Biomedical, Inc.?

Akeso Biomedical, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Akeso Biomedical, Inc. worth (valuation)?

Valuation information for Akeso Biomedical, Inc. is not publicly available.

Can I buy Akeso Biomedical, Inc. stock?

Akeso Biomedical, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Akeso Biomedical, Inc.'s last funding round?

Akeso Biomedical, Inc.'s most recent funding round was Pre Seed on February 9, 2021.

Who are the main investors in Akeso Biomedical, Inc.?

Key investors in Akeso Biomedical, Inc. include VIC Technology Venture Development.

Will Akeso Biomedical, Inc. IPO soon?

No public IPO plans have been announced for Akeso Biomedical, Inc..

How can I track Akeso Biomedical, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Akeso Biomedical, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBurlington, Massachusetts
Employee Range1
Year Founded2014
Last FundingFeb 9, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?